MHRA Drug Safety Update February 2022

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 15 Issue 7 February 2022) has been published and includes articles on:

  • COVID-19 antivirals: reporting to the UK COVID-19 Antivirals Pregnancy Registry
  • Hydroxychloroquine, chloroquine: increased risk of cardiovascular events when used with macrolide antibiotics; reminder of psychiatric reactions
  • Ivacaftor, tezacaftor, elexacaftor (Kaftrio▼) in combination with ivacaftor (Kalydeco): risk of serious liver injury; updated advice on liver function testing
  • COVID-19 vaccines and medicines: updates for February 2021
  • Letters and medicine recalls sent to healthcare professionals in January 2022

To see the latest MHRA Drug Safety Updates in full, visit the website